Lloyd-Smith E - Search Results

1

Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.

Mitra AR, Fergusson NA, Lloyd-Smith E, Wormsbecker A, Foster D, Karpov A, Crowe S, Haljan G, Chittock DR, Kanji HD, Sekhon MS, Griesdale DEG. Mitra AR, et al. Among authors: lloyd smith e. CMAJ. 2020 Jun 29;192(26):E694-E701. doi: 10.1503/cmaj.200794. Epub 2020 May 27. CMAJ. 2020. PMID: 32461326 Free PMC article.

2

Caractéristiques de départ et issues chez des patients atteints de COVID-19 hospitalisés dans des unités de soins intensifs à Vancouver (Canada) : série de cas.

Mitra AR, Fergusson NA, Lloyd-Smith E, Wormsbecker A, Foster D, Karpov A, Crowe S, Haljan G, Chittock DR, Kanji HD, Sekhon MS, Griesdale DEG. Mitra AR, et al. Among authors: lloyd smith e. CMAJ. 2020 Nov 23;192(47):E1550-E1558. doi: 10.1503/cmaj.200794-f. CMAJ. 2020. PMID: 33229353 Free PMC article. French.

3

Harmful microinjecting practices among a cohort of injection drug users in vancouver Canada.

Rachlis B, Lloyd-Smith E, Small W, Tobin D, Stone D, Li K, Wood E, Kerr T. Rachlis B, et al. Subst Use Misuse. 2010 Jul;45(9):1351-66. doi: 10.3109/10826081003767643. Subst Use Misuse. 2010. PMID: 20509739 Free PMC article.

4

Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia.

Lloyd-Smith E, Brodkin E, Wood E, Kerr T, Tyndall MW, Montaner JS, Hogg RS. Lloyd-Smith E, et al. AIDS. 2006 Feb 14;20(3):445-50. doi: 10.1097/01.aids.0000206508.32030.92. AIDS. 2006. PMID: 16439879

5

Frequent needle exchange use and HIV incidence in Vancouver, Canada.

Wood E, Lloyd-Smith E, Li K, Strathdee SA, Small W, Tyndall MW, Montaner JS, Kerr T. Wood E, et al. Am J Med. 2007 Feb;120(2):172-9. doi: 10.1016/j.amjmed.2006.02.030. Am J Med. 2007. PMID: 17275459

6

Polymerase chain reaction assay to detect Clostridium difficile tcdC variants is valuable in characterizing hospital epidemiology.

Wilmer A, Lloyd-Smith E, Leung V, Wong T, Ritchie G, Hoang L, Champagne S, Romney MG. Wilmer A, et al. J Hosp Infect. 2013 Jul;84(3):252-5. doi: 10.1016/j.jhin.2013.04.002. Epub 2013 May 20. J Hosp Infect. 2013. PMID: 23702278

7

Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study.

Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Sheps S, Montaner JS, Kerr T. Lloyd-Smith E, et al. BMC Public Health. 2010 Jun 9;10:327. doi: 10.1186/1471-2458-10-327. BMC Public Health. 2010. PMID: 20534148 Free PMC article.

8

Recent incarceration linked to cutaneous injection-related infections among active injection drug users in a Canadian setting.

Milloy MJ, Wood E, Lloyd-Smith E, Grafstein E, Tyndall M, Montaner J, Kerr T. Milloy MJ, et al. J Community Health. 2010 Dec;35(6):660-6. doi: 10.1007/s10900-010-9269-y. J Community Health. 2010. PMID: 20364303

9

Do supervised injecting facilities attract higher-risk injection drug users?

Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T. Wood E, et al. Am J Prev Med. 2005 Aug;29(2):126-30. doi: 10.1016/j.amepre.2005.04.011. Am J Prev Med. 2005. PMID: 16005809

10

Measuring adherence to highly active antiretroviral therapy: implications for research and practice.

Kerr T, Walsh J, Lloyd-Smith E, Wood E. Kerr T, et al. Curr HIV/AIDS Rep. 2005 Nov;2(4):200-5. doi: 10.1007/s11904-005-0017-3. Curr HIV/AIDS Rep. 2005. PMID: 16343379 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page